Urata Satoko, Izumi Kouji, Hiratsuka Kaoru, Maolake Aerken, Natsagdorj Ariunbold, Shigehara Kazuyoshi, Iwamoto Hiroaki, Kadomoto Suguru, Makino Tomoyuki, Naito Renato, Kadono Yoshifumi, Lin Wen-Jye, Wufuer Guzailinuer, Narimoto Kazutaka, Mizokami Atsushi
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.
Cancer Sci. 2018 Mar;109(3):724-731. doi: 10.1111/cas.13494. Epub 2018 Feb 14.
Chemokines and their receptors have key roles in cancer progression. The present study investigated chemokine activity in the prostate cancer bone metastasis microenvironment. Growth and migration of human prostate cancer cells were assayed in cocultures with bone stromal cells. The migration of LNCaP cells significantly increased when co-cultured with bone stromal cells isolated from prostate cancer bone metastases. Cytokine array analysis of conditioned medium from bone stromal cell cultures identified CCL5 as a concentration-dependent promoter of LNCaP cell migration. The migration of LNCaP cells was suppressed when C-C motif ligand 5 (CCL5) neutralizing antibody was added to cocultures with bone stromal cells. Knockdown of androgen receptor with small interfering RNA increased the migration of LNCaP cells compared with control cells, and CCL5 did not promote the migration of androgen receptor knockdown LNCaP. Elevated CCL5 secretion in bone stromal cells from metastatic lesions induced prostate cancer cell migration by a mechanism consistent with CCL5 activity upstream of androgen receptor signaling.
趋化因子及其受体在癌症进展中起关键作用。本研究调查了前列腺癌骨转移微环境中的趋化因子活性。在与骨基质细胞共培养中检测了人前列腺癌细胞的生长和迁移。当与从前列腺癌骨转移灶分离的骨基质细胞共培养时,LNCaP细胞的迁移显著增加。对骨基质细胞培养条件培养基的细胞因子阵列分析确定CCL5是LNCaP细胞迁移的浓度依赖性促进因子。当将C-C基序配体5(CCL5)中和抗体添加到与骨基质细胞的共培养物中时,LNCaP细胞的迁移受到抑制。与对照细胞相比,用小干扰RNA敲低雄激素受体增加了LNCaP细胞的迁移,并且CCL5不促进雄激素受体敲低的LNCaP细胞的迁移。转移灶骨基质细胞中CCL5分泌升高,通过与雄激素受体信号上游CCL5活性一致的机制诱导前列腺癌细胞迁移。